Disopyramide Sustained-Release Capsules and Moxetumomab pasudotox
Determining the interaction of Disopyramide Sustained-Release Capsules and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: disopyramide
Brand name: Norpace, Norpace CR
Synonyms: Disopyramide
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Disopyramide Sustained-Release Capsules-Moxetumomab Pasudotox-tdfk
- Disopyramide Sustained-Release Capsules-Moxetumomab pasudotox-tdfk Intravenous
- Disopyramide Sustained-Release Capsules-Moxifloxacin
- Disopyramide Sustained-Release Capsules-Moxifloxacin (Systemic)
- Disopyramide Sustained-Release Capsules-Moxifloxacin Hydrochloride
- Disopyramide Sustained-Release Capsules-Moxifloxacin Injection
- Moxetumomab pasudotox-DisperMox
- Moxetumomab pasudotox-Disposable Enema rectal
- Moxetumomab pasudotox-Disulfiram
- Moxetumomab pasudotox-Dithol Solution
- Moxetumomab pasudotox-Ditropan
- Moxetumomab pasudotox-Ditropan XL